Key result
Sodium glucose cotransporter-2 inhibitors improve glycaemic control and reduce mortality and hospital admissions in heart failure, with specialist nurses playing a key role in patient management.
Why the study?
Diabetes significantly increases morbidity and mortality in patients with heart failure, creating a need to review sodium glucose cotransporter-2 inhibitors, patient education, and the role of heart failure specialist nurses in prescribing and monitoring them.
What is the role of heart failure specialist nurses in the use of sodium glucose cotransporter-2 inhibitors for patients with heart failure?
What is the role of heart failure specialist nurses in the use of sodium glucose cotransporter-2 inhibitors for patients with heart failure?
Heart failure specialist nurses play a crucial role in the education, prescribing, and monitoring of SGLT2 inhibitors for patients with heart failure.
Answers are grounded in this paper and cite their sources.
Specialist nurses may enhance SGLT2 inhibitor uptake in heart failure; leaves open need for prospective trials on implementation.
Diabetes significantly increases the morbidity and mortality faced by patients with heart failure. Sodium glucose cotransporter-2 inhibitors can improve glycaemic control and reduce mortality. They can also improve the cardiovascular risk profile as well as act as a diuretic and reduce hospital admissions because of heart failure. This article will review how these medications work, their place in the treatment of heart failure and the patient education needed before starting these medications. The article will also discuss the role played by heart failure specialist nurses in prescribing and monitoring the impact of these medications on patients. The article concludes with a horizon scan of the potential future implications for heart failure specialist nurses of these medications.
No takes yet. Share an insight, caveat, or question.
M Melville (2019) conducted a review in Heart failure. Sodium glucose cotransporter-2 inhibitors was evaluated. Sodium glucose cotransporter-2 inhibitors improve glycaemic control and reduce mortality and hospital admissions in heart failure, with specialist nurses playing a key role in patient management.
Synapse has enriched 10 related papers. Consider them for comparative context: